These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 30353318)

  • 21. FGF23 in Chronic Kidney Disease: Bridging the Heart and Anemia.
    Figurek A; Rroji M; Spasovski G
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FGF23-αKlotho as a paradigm for a kidney-bone network.
    Kuro-O M; Moe OW
    Bone; 2017 Jul; 100():4-18. PubMed ID: 27847255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].
    Komaba H
    Clin Calcium; 2010 Jul; 20(7):1028-36. PubMed ID: 20585181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD.
    Clinkenbeard EL; Noonan ML; Thomas JC; Ni P; Hum JM; Aref M; Swallow EA; Moe SM; Allen MR; White KE
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.
    van Breda F; Emans ME; van der Putten K; Braam B; van Ittersum FJ; Kraaijenhagen RJ; de Borst MH; Vervloet M; Gaillard CA
    PLoS One; 2015; 10(6):e0128994. PubMed ID: 26079688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The HIF-PHI BAY 85-3934 (Molidustat) Improves Anemia and Is Associated With Reduced Levels of Circulating FGF23 in a CKD Mouse Model.
    Noonan ML; Ni P; Agoro R; Sacks SA; Swallow EA; Wheeler JA; Clinkenbeard EL; Capitano ML; Prideaux M; Atkins GJ; Thompson WR; Allen MR; Broxmeyer HE; White KE
    J Bone Miner Res; 2021 Jun; 36(6):1117-1130. PubMed ID: 33592127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The osteocyte in CKD: new concepts regarding the role of FGF23 in mineral metabolism and systemic complications.
    Wesseling-Perry K; Jüppner H
    Bone; 2013 Jun; 54(2):222-9. PubMed ID: 23079136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous management of disordered phosphate and iron homeostasis to correct fibroblast growth factor 23 and associated outcomes in chronic kidney disease.
    Courbon G; Martinez-Calle M; David V
    Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):359-366. PubMed ID: 32452919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of ferric citrate hydrate on FGF23 and PTH levels in patients with non-dialysis-dependent chronic kidney disease with normophosphatemia and iron deficiency.
    Iguchi A; Yamamoto S; Yamazaki M; Tasaki K; Suzuki Y; Kazama JJ; Narita I
    Clin Exp Nephrol; 2018 Aug; 22(4):789-796. PubMed ID: 29181658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroblast growth factor 23 is pumping iron: C-terminal-fibroblast growth factor 23 cleaved peptide and its function in iron metabolism.
    Courbon G; David V
    Curr Opin Nephrol Hypertens; 2024 Jul; 33(4):368-374. PubMed ID: 38661434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Segregating the effects of ferric citrate-mediated iron utilization and FGF23 in a mouse model of CKD.
    Liesen MP; Noonan ML; Ni P; Agoro R; Hum JM; Clinkenbeard EL; Damrath JG; Wallace JM; Swallow EA; Allen MR; White KE
    Physiol Rep; 2022 Jun; 10(11):e15307. PubMed ID: 35656701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FGF23 Actions in CKD-MBD and other Organs During CKD.
    Sun T; Yu X
    Curr Med Chem; 2023; 30(7):841-856. PubMed ID: 35761503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bone metabolism and cardiovascular function update. α-klotho/FGF23 system; a new insight into the field of mineral homeostasis and the pathogeneses of aging-associated syndromes and the complications of chronic kidney disease].
    Nabeshima YI
    Clin Calcium; 2014 Jul; 24(7):37-43. PubMed ID: 24976054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Klotho in bone and implication for CKD.
    Komaba H; Lanske B
    Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):298-304. PubMed ID: 29697410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Women and CKD-mineral and bone disorder.
    Ho LT; Sprague SM
    Adv Chronic Kidney Dis; 2013 Sep; 20(5):423-6. PubMed ID: 23978548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Cai X; Lee J; Scialla JJ; Bansal N; Sondheimer JH; Chen J; Hamm LL; Ricardo AC; Navaneethan SD; Deo R; Rahman M; Feldman HI; Go AS; Isakova T; Wolf M;
    JAMA Cardiol; 2016 Aug; 1(5):548-56. PubMed ID: 27434583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease.
    Panwar B; Gutiérrez OM
    Semin Nephrol; 2016 Jul; 36(4):252-61. PubMed ID: 27475656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease.
    Durlacher-Betzer K; Hassan A; Levi R; Axelrod J; Silver J; Naveh-Many T
    Kidney Int; 2018 Aug; 94(2):315-325. PubMed ID: 29861060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of fibroblast growth factor 23 in chronic kidney disease-mineral and bone disorder.
    Diniz H; Frazão JM
    Nefrologia; 2013 Nov; 33(6):835-44. PubMed ID: 24158124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial.
    Hanudel MR; Laster ML; Portale AA; Dokras A; Quigley RP; Guzman GAL; Zaritsky JJ; Hayde NA; Kaskel FJ; Mitsnefes MM; Ramirez JA; Imani PD; Srivaths PR; Kogon AJ; Denburg MR; Blydt-Hansen TD; Reyes LZ; Greenbaum LA; Weidemann DK; Warady BA; Elashoff DA; Mendley SR; Isakova T; Salusky IB
    Pediatr Nephrol; 2022 Nov; 37(11):2547-2557. PubMed ID: 35237863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.